XML 30 R13.htm IDEA: XBRL DOCUMENT v3.23.1
Business Segment and Geographical Information
 3 Months Ended
Apr. 01, 2023
Segment Reporting [Abstract]  
Business Segment and Geographical Information Business Segment and Geographical Information
Business Segment Information
Three months ended
April 1,April 2,
(In millions)20232022
Revenues
Life Sciences Solutions
$2,612 $4,231 
Analytical Instruments
1,723 1,518 
Specialty Diagnostics
1,108 1,482 
Laboratory Products and Biopharma Services
5,763 5,442 
Eliminations
(496)(855)
Consolidated revenues
10,710 11,818 
Segment Income
Life Sciences Solutions
836 2,176 
Analytical Instruments
421 301 
Specialty Diagnostics
280 353 
Laboratory Products and Biopharma Services
793 620 
Subtotal reportable segments
2,330 3,450 
Cost of revenues adjustments
(41)(11)
Selling, general and administrative expenses adjustments
(8)(7)
Restructuring and other costs
(112)(2)
Amortization of acquisition-related intangible assets
(606)(609)
Consolidated operating income
1,563 2,821 
Interest income 146 18 
Interest expense(300)(136)
Other income/(expense)
(46)(163)
Consolidated income before taxes
$1,363 $2,540 
Cost of revenues adjustments included in the above table consist of charges for the sale of inventories revalued at the date of acquisition and inventory write-downs associated with large-scale abandonment of product lines. Selling, general and administrative expenses adjustments included in the above table consist of third-party transaction/integration costs related to recent acquisitions and charges/credits for changes in estimates of contingent acquisition consideration.
Geographical Information
Revenues by country based on customer location are as follows:
Three months ended
(In millions)April 1, 2023April 2, 2022
Revenues
United States
$5,587 $6,097 
China
870 910 
Other
4,253 4,811 
Consolidated revenues
$10,710 $11,818